Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;39(4):656-661.
doi: 10.5114/ada.2021.112073. Epub 2022 Jan 18.

Skin manifestations of neuroendocrine neoplasms: review of the literature

Affiliations
Review

Skin manifestations of neuroendocrine neoplasms: review of the literature

Irena Walecka et al. Postepy Dermatol Alergol. 2022 Aug.

Abstract

Neuroendocrine neoplasms (NENs) are a heterogeneous group of rare tumours derived from peptidergic neurons and specialized neuroendocrine cells capable of secreting various peptides or amines. These cells may be present in endocrine tissue or diffused in the tissues of the digestive or respiratory system. The article reviews the characteristic features of NENs, with particular emphasis on skin manifestations, such as necrolytic migratory erythema (NME), tongue inflammation, angular cheilitis, venous thrombosis and alopecia in glucagonoma; "flushing", "lion face", pellagra skin symptoms, "scleroderma-like features without Raynaud's phenomenon" in carcinoid tumours. The paper also presents the clinical picture of the neuroendocrine tumour of the skin - Merkel cell carcinoma. The aim of this study was to draw attention to the need for precise and comprehensive diagnosis of the patients, with particular emphasis on skin lesions as a revelator of neuroendocrine tumours. This management allows for the early implementation of appropriate treatment.

Keywords: NET; carcinoid tumour; dermatology; glucagonoma; neuroendocrine neoplasms; skin manifestations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Modlin IM, Oberg K, Chung DC, et al. . Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9: 61-72. - PubMed
    1. Zamora V, Cabanne A, Salanova R, et al. . Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours. Dig Liver Dis 2010; 42: 220-5. - PubMed
    1. Oronsky B, Ma PC, Morgensztern D, et al. . Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia 2017; 19: 991-1002. - PMC - PubMed
    1. Medycyna Praktyczna . Nowotwory neuroendokrynne 2020 [cited 2020 10/08/2020]. Available from: https://www.mp.pl/interna/chapter/B16.II.12.1./
    1. Choe J, Kim KW, Kim HJ, et al. . What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms? Korean J Radiol 2019; 20: 5-17. - PMC - PubMed